Composition
- Active ingredients
- CILASTATIN SODIUM EQ 500MG BASE/VIAL; IMIPENEM 500MG/VIAL; RELEBACTAM 250MG/VIAL
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA212819.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Recarbrio
- Active substance
- cilastatin sodium
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- MSD Merck Co
- Status
- Prescription
- FDA approval
- 16 Jul 2019
- Application
- NDA212819-001